Skip to main content
. 2016 Feb 25;7(13):17074–17086. doi: 10.18632/oncotarget.7717

Figure 8. CRMP4 knockdown inhibits tumor growth in vivo.

Figure 8

Images showing examples of xenografted tumor growth in vivo at 42 days after injection with LV-CRMP4, LV-shCRMP4 or controls (LV-Ctrl) in SGC7901 A. and HGC27 B. cells in 4-week-old female BALB/c nu/nu mice. C. Statistical analysis of the tumor volume of the xenografted tumor in vivo after injection with LV-CRMP4, LV-shCRMP4 or control SGC7901 (C) or HGC27 D. cells in 4-week-old female BALB/c nu/nu mice. There was a significant increase in tumor size in the CRMP4 overexpression group and a significant reduction in tumor size in the LV-shCRMP4 group compared with the control groups. (*P < 0.05 vs control).